✦ LIBER ✦
331. Neoadjuvant folfiri + bevacizumab in patients with resectable liver metastases from colorectal cancer: Results from a phase 2 trial and comparative analysis of early PET/CT scan vs RECIST criteria in predicting outcome
✍ Scribed by Izzo, F.; Palaia, R.; Albino, V.; Di Giacomo, R.; Amore, A.; Saponara, R.; Leongito, M.; Nasti, G.; Lastoria, S.
- Book ID
- 126704769
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 43 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0748-7983
No coin nor oath required. For personal study only.